The tau theory posits a correlation between the quantity and distribution of hyperphosphorylated tau aggregates and cognitive decline, with tau-PET metrics strongly predicting clinical trajectories in AD (Biel et al., 2022; Ioannou et al., 2025). This evidence concerns the gene MAPT and Alzheimer disease.